The Cirrhosis Outpatient Optimization, Readmission & Safety Study
Public ClinicalTrials.gov record NCT02457988. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
COORS: The Cirrhosis Outpatient Optimization, Readmission & Safety Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective series comparing care incorporating home monitoring and liver care coordination to conventional care for patients with cirrhosis.
Study identification
- NCT ID
- NCT02457988
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Early Phase 1
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2015
- Primary completion
- Sep 30, 2017
- Completion
- Sep 30, 2017
- Last update posted
- Dec 21, 2025
2015 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Center for Inflammatory Bowel Diseases | Los Angeles | California | 90095 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cirrhosis trials
Other public records listing Cirrhosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07029243: Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis Recruiting
- NCT06941415: Bumetanide vs. Furosemide in Cirrhosis Recruiting
- NCT05548452: Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease Recruiting
- NCT07568275: Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance Active, not recruiting
- NCT02968810: Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Active, not recruiting
- NCT05170854: The Impact of Liver Cirrhosis on Outcomes in Trauma Patients Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02457988, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2025 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02457988 live on ClinicalTrials.gov.